Underuse of colorectal cancer screening among men screened for prostate cancer: a teachable moment?
- PMID: 20578178
- PMCID: PMC3639486
- DOI: 10.1002/cncr.25229
Underuse of colorectal cancer screening among men screened for prostate cancer: a teachable moment?
Abstract
Background: Evidence suggests that colorectal cancer (CRC) screening reduces disease-specific mortality, whereas the utility of prostate cancer screening remains uncertain. However, adherence rates for prostate cancer screening and CRC screening are very similar, with population-based studies showing that approximately 50% of eligible US men are adherent to both tests. Among men scheduled to participate in a free prostate cancer screening program, the authors assessed the rates and correlates of CRC screening to determine the utility of this setting for addressing CRC screening nonadherence.
Methods: Participants (N = 331) were 50 to 70 years old with no history of prostate cancer or CRC. Men registered for free prostate cancer screening and completed a telephone interview 1 to 2 weeks before undergoing prostate cancer screening.
Results: One half of the participants who underwent free prostate cancer screening were eligible for but nonadherent to CRC screening. Importantly, 76% of the men who were nonadherent to CRC screening had a regular physician and/or health insurance, suggesting that CRC screening adherence was feasible in this group. Furthermore, multivariate analyses indicated that the only significant correlates of CRC screening adherence were having a regular physician, health insurance, and a history of prostate cancer screening.
Conclusions: Free prostate cancer screening programs may provide a teachable moment to increase CRC screening among men who may not have the usual systemic barriers to CRC screening, at a time when they may be very receptive to cancer screening messages. In the United States, a large number of men participate in annual free prostate cancer screening programs and represent an easily accessible and untapped group that can benefit from interventions to increase CRC screening rates.
© 2010 American Cancer Society.
Similar articles
-
Rates and predictors of colorectal cancer screening by race among motivated men participating in a Prostate Cancer Risk Assessment Program.Cancer. 2012 Jan 15;118(2):478-84. doi: 10.1002/cncr.26315. Epub 2011 Jul 12. Cancer. 2012. PMID: 21751189 Free PMC article.
-
Correlates of colorectal cancer screening adherence among men who have been screened for prostate cancer.J Cancer Educ. 2011 Jun;26(2):301-7. doi: 10.1007/s13187-011-0194-2. J Cancer Educ. 2011. PMID: 21360029 Free PMC article. Clinical Trial.
-
Behavioral associations between prostate and colon cancer screening.J Am Coll Surg. 2005 Feb;200(2):216-23. doi: 10.1016/j.jamcollsurg.2004.10.015. J Am Coll Surg. 2005. PMID: 15664097
-
Prostate and Colorectal Cancer Screening Uptake among US and Foreign-Born Males: Evidence from the 2015 NHIS Survey.J Community Health. 2017 Jun;42(3):612-623. doi: 10.1007/s10900-016-0296-1. J Community Health. 2017. PMID: 27838809
-
A pilot study for using fecal immunochemical testing to increase colorectal cancer screening in Appalachia, 2008-2009.Prev Chronic Dis. 2012;9:E77. Prev Chronic Dis. 2012. PMID: 22482136 Free PMC article.
Cited by
-
Who are the under- and never-screened for cancer in Ontario: a qualitative investigation.BMC Public Health. 2014 May 23;14:495. doi: 10.1186/1471-2458-14-495. BMC Public Health. 2014. PMID: 24885998 Free PMC article.
-
Rates and predictors of colorectal cancer screening by race among motivated men participating in a Prostate Cancer Risk Assessment Program.Cancer. 2012 Jan 15;118(2):478-84. doi: 10.1002/cncr.26315. Epub 2011 Jul 12. Cancer. 2012. PMID: 21751189 Free PMC article.
-
Correlates of colorectal cancer screening adherence among men who have been screened for prostate cancer.J Cancer Educ. 2011 Jun;26(2):301-7. doi: 10.1007/s13187-011-0194-2. J Cancer Educ. 2011. PMID: 21360029 Free PMC article. Clinical Trial.
-
Sociodemographic and health-related predictors of self-reported mammogram, faecal occult blood test and prostate specific antigen test use in a large Australian study.BMC Public Health. 2013 May 3;13:429. doi: 10.1186/1471-2458-13-429. BMC Public Health. 2013. PMID: 23641775 Free PMC article.
References
-
- American Cancer Society. Recent prostate-specific antigen (PSA) test prevalence (%), by educational attainment and health insurance status, men 50 years and older, US, 2001-2006. [July 17, 2009];Cancer Statistics 2009: A Presentation From the American Cancer Society. [slide]. Available at: http://www.cancer.org/downloads/PRO/Cancer_Statistics_Slides_2009.ppt.
-
- Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348:1472–1477. - PubMed
-
- Mandel JS. Screening for colon and rectal cancer. [July 17, 2009]; Available at: http://www.moffitt.org/moffittapps/ccj/v3n2/dept7.html. - PubMed
-
- Smith RA, Cokkinides V, Eyre HJ. American Cancer Society guidelines for the early detection of cancer, 2009. CA Cancer J Clin. 2009;59:27–41. - PubMed
-
- U.S. Preventive Services Task Force. Guide to Clinical Preventive Services. 2. Baltimore, MD: Williams & Wilkins; 1996.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical